Intestinal fibrosis is one of the most threatening complications of Crohn's disease. It occurs in
more than a third of patients with this condition, is associated with increased morbidity and …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease involving mainly the
colorectal mucosa and submucosa, the incidence of which has been on the rise in recent …

Background Regulating the microglial phenotype is an attractive strategy for treating
diseases of the central nervous system such as depression and anxiety. Gastrodin can …

Introduction Oxidative stress and inflammatory responses are critical factors in ulcerative
colitis disease pathogenesis. Nuclear factor erythroid 2-related factor 2 (Nrf2) modulates …

The emerging concept that “the maximized therapeutic efficacy of encapsulates would be
achieved by inducing appropriate absorption site and pharmacological signal pathways …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology that
increases the risk of developing colorectal cancer and imposes a lifelong healthcare burden …

Abstract Background Creeping fat (CrF) has been recognized to play a positive role in
Crohn's disease (CD) progression, yet the cellular compositions within mesenteric adipose …

Early diagnosis and prognosis are prerequisites for mitigating mortality in gastric cancer
(GaCa). Identifying some causative or sensitive elements (coding RNA (cRNA)-non-cRNAs …

Inflammatory bowel disease (IBD) is a special chronic intestinal inflammatory disease, which
is mainly divided into Crohn's disease (CD) and ulcerative colitis (UC). Its occurrence is a …

Intestinal fibrosis is a prevalent complication of Crohn's disease (CD), characterized by
excessive deposition of extracellular matrix (ECM), and no approved drugs are currently …